Compounds > 2,4-methanoglutamate
Page last updated: 2024-10-21

2,4-methanoglutamate and Brain Diseases

2,4-methanoglutamate has been researched along with Brain Diseases in 1 studies

2,4-methanoglutamate: structure given in first source; selective N-methyl-D-aspartate receptor agonist; inhibits high affinity L-glutamic acid uptake into rat cortical synaptosomes; RN given for (trans)-isomer

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Feuvre, RA1
Brough, D1
Touzani, O1
Rothwell, NJ1

Other Studies

1 other study available for 2,4-methanoglutamate and Brain Diseases

ArticleYear
Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2003, Volume: 23, Issue:3

    Topics: Animals; Brain Diseases; Cell Death; Glutamates; Interleukin 1 Receptor Antagonist Protein; Interleu

2003